XpresSpa Group Announces Agreement with 98point6 as the Treat™ Partner for Virtual Care
“This partnership with a telehealth industry leader, 98point6, will allow us to fuel an important component for one of the key features of our new app launch later this month,” said
98point6 is an on-demand, text-based primary care service that delivers personalized diagnosis, treatment and consultation to patients across the country. 98point6 board-certified physicians will consult with
“Our mission is to ensure everyone has access to quality, affordable and convenient primary care no matter where they are,” said
Founded in 2015, 98point6 is pioneering a new approach to primary care. By pairing AI and machine learning with board-certified physicians, our vision is to make primary care more accessible and affordable, leading to better health. We meet consumers where they are by offering private, text-based diagnosis and treatment via a mobile app. For employers, health plans, health systems and retail partners, 98point6 increases primary care utilization among those not actively or appropriately engaged in their health—enabling earlier medical intervention and reducing overall cost of care. For more information about 98point6, visit www.98point6.com.
To learn more about Treat, visit: www.TreatCare.com.
To learn more about XpresCheck, visit: www.XpresCheck.com.
To learn more about
Twitter: @Treat_Care and Instagram: @treat_care
Twitter: @xprescheck and Instagram: @realxprescheck
Twitter @XpresSpa and Instagram: @XpresSpa
This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations as they become available, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our ability further expand our initial sites and our overall ability to manage the regulatory challenges associated with this business line. Forward-looking statements relating to expectations about future results or events are based upon information available to
Source: XpresSpa Group, Inc.